Kathleen A. Rickard Verona Pharma PLC (VRNA) insider trading activity

Kathleen A. Rickard is Chief Medical Officer of Verona Pharma plc. Currently has a direct ownership of 2.55 Million shares of VRNA, which is worth approximately $192 Million. The most recent transaction as insider was on May 06, 2025, when has been sold 114,984 shares (Ordinary Shares) at a price of $8.82 per share, resulting in proceeds of $1,014,158. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.55M

5.27% 3M change

2.86% 12M change

Total Value Held $192 Million

Kathleen A. Rickard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 06 2025	SELL Open market or private sale	$1,014,158 $8.82 p/Share	114,984 Reduced 4.32%	2,546,472 Ordinary Shares
May 01 2025	SELL Open market or private sale	$440,339 $8.95 p/Share	49,200 Reduced 1.82%	2,661,456 Ordinary Shares
May 01 2025	BUY Exercise of conversion of derivative security	-	50,000 Added 1.83%	2,683,320 Ordinary Shares
Apr 29 2025	SELL Open market or private sale	$308,768 $8.98 p/Share	34,384 Reduced 1.28%	2,660,656 Ordinary Shares
Apr 29 2025	BUY Exercise of conversion of derivative security	-	86,064 Added 3.09%	2,695,040 Ordinary Shares
Mar 12 2025	SELL Open market or private sale	$661,854 $8.35 p/Share	79,264 Reduced 2.95%	2,608,976 Ordinary Shares
Feb 03 2025	SELL Payment of exercise price or tax liability	$237,998 $7.16 p/Share	33,240 Reduced 1.22%	2,688,240 Ordinary Shares
Feb 01 2025	BUY Grant, award, or other acquisition	-	50,000 Added 1.8%	2,721,480 Ordinary Shares
Nov 25 2024	SELL Open market or private sale	$1,176,000 $4.9 p/Share	240,000 Reduced 8.24%	2,671,480 Ordinary Shares
Nov 01 2024	SELL Payment of exercise price or tax liability	$279,568 $4.24 p/Share	65,936 Reduced 2.21%	2,911,480 Ordinary Shares
Nov 01 2024	BUY Grant, award, or other acquisition	-	50,000 Added 1.65%	2,977,416 Ordinary Shares
Oct 30 2024	BUY Grant, award, or other acquisition	-	300,000 Added 9.3%	2,927,416 Ordinary Shares
Aug 07 2024	SELL Payment of exercise price or tax liability	$230,308 $2.62 p/Share	87,904 Reduced 3.24%	2,627,416 Ordinary Shares
Aug 07 2024	BUY Grant, award, or other acquisition	-	200,000 Added 6.86%	2,715,320 Ordinary Shares
Aug 01 2024	SELL Payment of exercise price or tax liability	$300,636 $2.83 p/Share	106,232 Reduced 4.05%	2,515,320 Ordinary Shares
May 03 2024	SELL Open market or private sale	$71,046 $1.96 p/Share	36,248 Reduced 1.36%	2,621,552 Ordinary Shares
May 01 2024	SELL Payment of exercise price or tax liability	$142,480 $1.93 p/Share	73,824 Reduced 2.7%	2,657,800 Ordinary Shares
Feb 05 2024	SELL Open market or private sale	$80,470 $2.22 p/Share	36,248 Reduced 1.31%	2,731,624 Ordinary Shares
Feb 01 2024	SELL Payment of exercise price or tax liability	$166,638 $2.29 p/Share	72,768 Reduced 2.56%	2,767,872 Ordinary Shares
Nov 03 2023	SELL Open market or private sale	$112,803 $1.92 p/Share	58,752 Reduced 2.03%	2,840,640 Ordinary Shares
Nov 01 2023	SELL Payment of exercise price or tax liability	$301,256 $1.74 p/Share	173,136 Reduced 5.63%	2,899,392 Ordinary Shares
Oct 20 2023	BUY Grant, award, or other acquisition	-	200,000 Added 6.11%	3,072,528 Ordinary Shares
Aug 07 2023	SELL Open market or private sale	$3,952 $2.47 p/Share	1,600 Reduced 0.06%	2,872,528 Ordinary Shares
Aug 04 2023	SELL Open market or private sale	$69,860 $2.5 p/Share	27,944 Reduced 0.96%	2,874,128 Ordinary Shares
Aug 03 2023	SELL Open market or private sale	$129,029 $2.55 p/Share	50,600 Reduced 1.71%	2,902,072 Ordinary Shares

KAR

Kathleen A. Rickard

Chief Medical Officer

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verona Pharma plc

Track Activities on VRNA

Account